Skip to main content
Log in

Targeting brain-tumor stem cells

  • News & Views
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Compounds that act on mechanisms associated with resistance of glioblastoma stem cells show efficacy in mouse models.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Targeting glioblastoma treatment to the tumor stem-cell compartment.

Kim Caesar

References

  1. Bao, S. et al. Nature 444, 756–760 (2006).

    Article  CAS  Google Scholar 

  2. Piccirillo, S.G. et al. Nature 444, 761–765 (2006).

    Article  CAS  Google Scholar 

  3. Stupp, R. et al. N. Engl. J. Med. 352, 987–996 (2005).

    Article  CAS  Google Scholar 

  4. Singh, S.K. et al. Nature 432, 396–401 (2004).

    Article  CAS  Google Scholar 

  5. Phillips, T.M., McBride, W.H. & Pajonk, F. J. Natl. Cancer Inst. 98, 1777–1785 (2006).

    Article  Google Scholar 

  6. Hegi, M.E. et al. N. Engl. J. Med. 352, 997–1003 (2005).

    Article  CAS  Google Scholar 

  7. Potti, A. et al. Nat. Med. 12, 1294–1300 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stupp, R., Hegi, M. Targeting brain-tumor stem cells. Nat Biotechnol 25, 193–194 (2007). https://doi.org/10.1038/nbt0207-193

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0207-193

  • Springer Nature America, Inc.

This article is cited by

Navigation